What we do
The secret to infection control is catching it quickly.
But current diagnostic systems are too slow, expensive, and cost lives.
Aksense is the solution. It can be used by anyone to diagnose infections in minutes, resulting in patients being treated quicker and the spread of infection being reduced, ultimately saving lives.
THE PROBLEM
The current diagnostic method is slow, inaccurate, expensive, and costs lives
Patients are waiting up to 3 days for results
Infections are only be diagnosed in laboratories with current technologies and takes from 1 to 3 days. This is a heavy workload for the doctors which can cause human error and increases the risk of mortality for patients.
Diagnostic methods are complex and expensive
The current diagnostic methods require a specific sample of the infection from the patient. The sample must be in an acceptable size. There are multiple steps in preparing the sample, which require skilled technicians and expensive laboratory equipment.
Diagnoses are not always accurate
The detection of the pathogens in the patient sample can give false negatives under antibiotic treatment. False positives can make it very difficult to distinguish colonisation from a real infection.
Lengthy diagnosis increase the healthcare cost
The diagnosis of infection within days results in blocking hospital beds and using unnecessary and exponential antibiotics. Current diagnostic systems increase healthcare and economic cost with longer hospitalisation and inefficient treatment.
Global facts about healthcare-associated infections
0
extra-days of hospital stay
caused by healthcare-associated infections
36 hours
to undertake a culture and sensitivity analysis using current methods
leaving physicians with no choice but to blindly treat a patient
THE SOLUTION
We developed a blood-based point of care biosensor that saves lives
Aksense has developed a blood-based point of care biosensor that provides a quick diagnose for healthcare-associated infections caused by Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumonia, Staphylococcus aureus, Enterococcus faecium, and Enterococcus faecalis.
Aksense uses state-of-the-art technology
Instead of taking a patient sample and running the current process of identifying the type of bacteria. Aksense measures the host response against the pathogen with proteomic and electrochemical sensing technology.
Aksense provides results in minutes, not days
One drop of blood sample is put directly on to Aksense’s sensors with no prior preparation required and get the infection results in minutes.
We measure it electrochemically. The results are presented on the device screen within minutes.
Aksense is clinically proved
Aksense sensors bind the targets in whole blood samples showing 100% sensitive and 91% specificity in two independent clinical studies to diagnose the Healthcare-associated infections.
Our Supporters
HOW WE DO IT
Aksense are measuring infections
Aksense is a bedside device that can diagnose infections based on the body’s reaction to seven different pathogenic bacteria that are responsible for major healthcare-associated infections.
Aksense reduces hospitalisation and unnecessary use of antibiotics
It can be used by any medical staff to get an infection result in minutes. The doctor can give efficient and quick treatment near the patient. It reduces at least 3 days hospitalization and unnecessary use of antibiotics.
We have successfully completed clinical trials with over 400 patients in intensive care units.